Almost one in four Medicaid beneficiaries in the USA is enrolled in managed care plans, according to the Clinton administration, which noted that an increase of three million in the past year was caused by a need by both the states and the federal government to expand coverage and stretch the health care dollar. Nearly eight million are enrolled in such programs now.
The federal government has also granted states waivers to start managed care demonstration projects and another eight are pending. The Health Care Financing Administration requires that Medicaid managed care plans cost no more than the federal government would pay for comparable fee-for-service care.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze